REAFIDE Trademark

Trademark Overview

On Wednesday, March 31, 2010, a trademark application was filed for REAFIDE with the United States Patent and Trademark Office. The USPTO has given the REAFIDE trademark a serial number of 79082188. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, March 31, 2020. This trademark is owned by Astellas Pharma Inc.. The REAFIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances, namely, anticoagulants and antithrombotic agents
reafide

General Information

Serial Number79082188
Word MarkREAFIDE
Filing DateWednesday, March 31, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, March 31, 2020
Registration Number4058064
Registration DateTuesday, November 22, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2011

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations and substances, namely, anticoagulants and antithrombotic agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 29, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Saturday, April 17, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, April 17, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, May 17, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Friday, March 8, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, March 8, 2019INVALIDATION PROCESSED
Thursday, February 28, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 29, 2018CANCELLED SECTION 71
Tuesday, November 22, 2016COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, April 29, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 15, 2013CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, July 13, 2013CORRECTION TRANSACTION RECEIVED FROM IB
Friday, May 31, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, July 14, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, June 26, 2012FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 26, 2012FINAL DISPOSITION PROCESSED
Friday, June 15, 2012NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 22, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 22, 2011REGISTERED-PRINCIPAL REGISTER
Saturday, October 29, 2011NOTIFICATION PROCESSED BY IB
Wednesday, October 26, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 26, 2011NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, September 6, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2011PUBLISHED FOR OPPOSITION
Wednesday, August 17, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 17, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, July 29, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 27, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 27, 2011EXAMINER'S AMENDMENT ENTERED
Wednesday, July 27, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 27, 2011EXAMINERS AMENDMENT E-MAILED
Wednesday, July 27, 2011EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 2, 2011NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 2, 2011FINAL REFUSAL E-MAILED
Wednesday, February 2, 2011FINAL REFUSAL WRITTEN
Wednesday, February 2, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 2, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 31, 2011ASSIGNED TO LIE
Wednesday, January 26, 2011TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, January 6, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 6, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 6, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 19, 2010NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 30, 2010REFUSAL PROCESSED BY IB
Thursday, July 8, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 8, 2010REFUSAL PROCESSED BY MPU
Thursday, July 8, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 7, 2010NON-FINAL ACTION WRITTEN
Tuesday, June 29, 2010ASSIGNED TO EXAMINER
Tuesday, June 1, 2010APPLICATION FILING RECEIPT MAILED
Thursday, May 27, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 20, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

reafide antithrombotic agents anticoagulants namely preparations substances pharmaceutical